Three hundredth Company to get listed on BSE SME Platform
Mumbai, May 23, 2019: SEBI came out with detailed guidelines on 18th May, 2010 for launching of SME Exchange/Platform. BSE became the first stock exchange to get the approval from SEBI and launch its SME platform on 13th March, 2012.
Cian Healthcare Limited became 300th company to get listed on the BSE SME Platform on May 23, 2019. Cian Healthcare Limited came out with an initial public offering of 62,16,000 Equity Shares of Rs.10/- Each (“Equity Shares”) For Cash At a Price Of Rs. 61/- Per Equity Share (The “Offer Price”), Aggregating to Rs. ’3791.00’ lacs. The company has successfully completed its public issue on May 15, 2019.
Cian Healthcare Limited is a Maharashtra based company whose registered office is at Pune. The Company is engaged into Manufacturing and developing of commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, along with 10 sales division focused on developing and growing our engagements in specialist and super specialist division. Our company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies.
Mumbai based Fedex Securities Private Limited was the lead managers Cian Healthcare Limited.
The 300 companies listed on BSE SME Platform have raised Rs. 3152.94 crores from the market and total market capitalization of 300 companies as on May 23, 2019 is 17958.78 Crores. BSE is the market leader in this segment with a market share of 60.24 percent.
The response since the launch of this platform by BSE has been very positive.
